Literature DB >> 33089379

Metabolic programming of nephron progenitor cell fate.

Giovane G Tortelote1, Mariel Colón-Leyva1, Zubaida Saifudeen2.   

Abstract

Metabolic pathways are one of the first responses at the cellular level to maternal/fetal interface stressors. Studies have revealed the previously unrecognized contributions of intermediary metabolism to developmental programs. Here, we provide an overview of cellular metabolic pathways and the cues that modulate metabolic states. We discuss the developmental and physiological implications of metabolic reprogramming and the key role of metabolites in epigenetic and epiproteomic modifications during embryonic development and with respect to kidney development and nephrogenesis.

Entities:  

Keywords:  Development; Embryonic kidney; Epigenome; Epiproteome; Glycolysis; Metabolic plasticity; Metabolites; OxPhos

Mesh：

Year:  2020        PMID： 33089379     DOI： 10.1007/s00467-020-04752-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  80 in total

Review 1.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

Review 2.  Genetic basis of human congenital anomalies of the kidney and urinary tract.

Authors:  Simone Sanna-Cherchi; Rik Westland; Gian Marco Ghiggeri; Ali G Gharavi
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 3.  Metabolic requirements of the nephron.

Authors:  Kasey Cargill; Sunder Sims-Lucas
Journal:  Pediatr Nephrol       Date:  2018-12-15       Impact factor: 3.714

Review 4.  Maternal nutrition, low nephron number and arterial hypertension in later life.

Authors:  Kerstin Benz; Kerstin Amann
Journal:  Biochim Biophys Acta       Date:  2010-03-10

5.  Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State.

Authors:  Wen Gu; Xavier Gaeta; Anna Sahakyan; Alanna B Chan; Candice S Hong; Rachel Kim; Daniel Braas; Kathrin Plath; William E Lowry; Heather R Christofk
Journal:  Cell Stem Cell       Date:  2016-09-08       Impact factor: 24.633

Review 6.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

Review 7.  Metabolic regulation of cell growth and proliferation.

Authors:  Jiajun Zhu; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

Review 8.  Energy metabolism plasticity enables stemness programs.

Authors:  Clifford D L Folmes; Timothy J Nelson; Petras P Dzeja; Andre Terzic
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 6.499

Review 9.  Developmental origins of chronic renal disease: an integrative hypothesis.

Authors:  F Boubred; M Saint-Faust; C Buffat; I Ligi; I Grandvuillemin; U Simeoni
Journal:  Int J Nephrol       Date:  2013-08-29

10.  Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism.

Authors:  John C Schell; Dona R Wisidagama; Claire Bensard; Helong Zhao; Peng Wei; Jason Tanner; Aimee Flores; Jeffrey Mohlman; Lise K Sorensen; Christian S Earl; Kristofor A Olson; Ren Miao; T Cameron Waller; Don Delker; Priyanka Kanth; Lei Jiang; Ralph J DeBerardinis; Mary P Bronner; Dean Y Li; James E Cox; Heather R Christofk; William E Lowry; Carl S Thummel; Jared Rutter
Journal:  Nat Cell Biol       Date:  2017-08-14       Impact factor: 28.824
View more
  1 in total

Review 1.  Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs.

Authors:  Valerie A Luyckx; Robert L Chevalier
Journal:  Exp Physiol       Date:  2022-01-17       Impact factor: 2.858
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.